Nationwide Drug Alert : Over 100+ Trusted Medicines Fail to Meet Standard : CDSCO June Updates

Date:

Share post:

Nationwide Drug Alert : Over 100+ Trusted Medicines Fail to Meet Standard : CDSCO June Updates

PharmaGenDRx News Bureau, – July 24, 2025

09:30 AM IST

Marking a key alert in national drug safety the Central Drugs Standard Control Organization (CDSCO) along with various State Drug Testing Laboratories have identified over 100 drug batches as Not of Standard Quality (NSQ) for June 2025 including commonly used medications like Pantoprazole, Paracetamol, Telmisartan, Rabeprazole, Azithromycin Suspension, Calamine lotion and multiple other injections from trusted manufacturers.

Discrepancies found in product sterility, assay levels, dissolution, presence of contamination and labeling. Manufactured by trusted firms across Himachal Pradesh, Maharashtra, Gujarat, Tamil Nadu and other pharma hubs raising concerns about manufacturing practices and regulatory oversight.

CDSCO as per its monthly surveillance alerts consumers, pharmacists and healthcare professionals and is urged to refer to the official NSQ list on the CDSCO portal and immediately report any suspected substandard drugs to ensure patient safety.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Dabur India Plant Under US FDA Scanner Over Contamination Concerns

The United States Food and Drug Administration (US FDA) has flagged serious concerns at Dabur India's manufacturing facility...

FDA Approves Wockhardt’s Novel Antibiotic ZAYNICH™️ for cUTI

Wockhardt Limited  announced that the U.S. Food and Drug Administration (FDA) has approved ZAYNICH™ (cefepimeand zidebactam), a novel intravenous antibiotic...

Relief for Patients: NPPA Fixes Ceiling Prices for 30 Essential Medicines

The National Pharmaceutical Pricing Authority (NPPA) has notified ceiling prices for 30 essential fixed-dose combination medicines under the...

FDA Draft Guidance Aims to Reduce Animal Testing for Cancer Drugs

The U.S. Food and Drug Administration (FDA) issued a new draft guidance aimed at reducing unnecessary animal testing...